BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas
| Հիմնական հեղինակներ: | , , , , , |
|---|---|
| Ձևաչափ: | Conference item |
| Հրապարակվել է: |
2008
|
| _version_ | 1826279717883346944 |
|---|---|
| author | Nyman, H Jerkeman, M Karjalainen-Lindsberg, M Banham, A Enblad, G Leppa, S |
| author_facet | Nyman, H Jerkeman, M Karjalainen-Lindsberg, M Banham, A Enblad, G Leppa, S |
| author_sort | Nyman, H |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T00:02:57Z |
| format | Conference item |
| id | oxford-uuid:769965b8-92e3-49b8-bef5-e8be5c4a5499 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T00:02:57Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:769965b8-92e3-49b8-bef5-e8be5c4a54992022-03-26T20:17:17ZBCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomasConference itemhttp://purl.org/coar/resource_type/c_5794uuid:769965b8-92e3-49b8-bef5-e8be5c4a5499Symplectic Elements at Oxford2008Nyman, HJerkeman, MKarjalainen-Lindsberg, MBanham, AEnblad, GLeppa, S |
| spellingShingle | Nyman, H Jerkeman, M Karjalainen-Lindsberg, M Banham, A Enblad, G Leppa, S BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas |
| title | BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas |
| title_full | BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas |
| title_fullStr | BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas |
| title_full_unstemmed | BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas |
| title_short | BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas |
| title_sort | bcl 2 but not foxp1 is an adverse risk factor in immunochemotherapy treated non germinal center diffuse large b cell lymphomas |
| work_keys_str_mv | AT nymanh bcl2butnotfoxp1isanadverseriskfactorinimmunochemotherapytreatednongerminalcenterdiffuselargebcelllymphomas AT jerkemanm bcl2butnotfoxp1isanadverseriskfactorinimmunochemotherapytreatednongerminalcenterdiffuselargebcelllymphomas AT karjalainenlindsbergm bcl2butnotfoxp1isanadverseriskfactorinimmunochemotherapytreatednongerminalcenterdiffuselargebcelllymphomas AT banhama bcl2butnotfoxp1isanadverseriskfactorinimmunochemotherapytreatednongerminalcenterdiffuselargebcelllymphomas AT enbladg bcl2butnotfoxp1isanadverseriskfactorinimmunochemotherapytreatednongerminalcenterdiffuselargebcelllymphomas AT leppas bcl2butnotfoxp1isanadverseriskfactorinimmunochemotherapytreatednongerminalcenterdiffuselargebcelllymphomas |